Why Is Walgreens Boots Alliance Stock Trading Higher On Tuesday?

Group 1 - Walgreens Boots Alliance Inc is in talks for a potential acquisition by Sycamore Partners, with its market value declining from over $100 billion to approximately $8.4 billion over the past decade [1] - The deal, which seemed "mostly dead" a few weeks ago, has been upgraded to "alive" according to CNBC, with potential completion in early 2025 [2] - Walgreens has suspended its cash dividend as part of a long-term turnaround strategy, reporting first-quarter sales of $39.46 billion, a 7.5% increase year over year, exceeding the consensus of $37.28 billion [3] Group 2 - The company anticipates growth in U.S. Healthcare and International segments, but expects pressure in U.S. Retail Pharmacy due to weaker retail front-end performance [4] - The U.S. Department of Justice has filed a civil complaint against Walgreens for alleged violations of the Controlled Substances Act and False Claims Act, claiming the company dispensed millions of unlawful prescriptions [5] - Walgreens stock has increased by 12.1%, reaching $10.88 [5]